# Bioequivalence Study of Metformin HCl 750 mg XR Tablets Under Non Fasting Conditions

> **NCT00778141** · NA · COMPLETED · sponsor: **Ranbaxy Laboratories Limited** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** metformin HC1 750 mg extended-release tablets

## Key facts

- **NCT ID:** NCT00778141
- **Lead sponsor:** Ranbaxy Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2004-04
- **Final completion:** 2004-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2008-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00778141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00778141, "Bioequivalence Study of Metformin HCl 750 mg XR Tablets Under Non Fasting Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00778141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*